Fmr. MedMen CEO Adam Bierman Breaks The Silence: 'We Were Doing Things For The First Time, Inevitably Pissing People Off'

The Rise Of MedMen

Bierman noted that the mainstreaming of cannabis through MedMen’s branding platform opened the door for new money that eventually attracted the attention of “ long-term investors (...). We were the first to go on TV and say “we are a marihuana company and we are proud of it.” 

A pioneers story.

Continue reading the article below or watch the full interview on YouTube.

The Construction Of MedMen, The Brand

Bierman went into detail about his participation in the construction of the brand MedMen and how from the beginning they were trying to mainstream corporate cannabis, change the customer experience and build physical permanence, starting for New York City, so people would become familiar with the plant and its benefits. 

He noted that he is “proud” and “excited” to talk about MedMen’s branding, “but in a weird way.”  

“We had to open a store on 5th Avenue so people in Buenos Aires would talk about it!. We had to provide the service so that when people flew into LA from Buenos Aires and went to a MedMen store somebody was there to greet them at the front and say ‘welcome to the future. Right? That person at the front costs a lot of money, they are creating an experience, that is an investment in a brand.”

Cannabis Culture and Corporate Cannabis

Bierman offered his own experience as a witness case to explain the industrial evolution that left him out of the C-Suite at MedMen.

The PharmaCann Story

Building the first nationwide mainstream marijuana company was not easy and the trajectory of Adam as CEO was full of surprises and setbacks. He explained that the fall of the PharmaCann deal was one of three main reasons behind the “downward death spiral of MedMen’s stock.” 

He noted this was the first time a cannabis transaction like that had to go through the antitrust process in the U.S. “Just think about that, it's a federally illegal business but it qualifies to go through this process so what a confusing place for the DOJ to be in. 

Mea Culpa?

Talent Acquisition: “One Of The Biggest Issues At MedMen” 

Although Bierman supports the idea of executives leading top-tier companies, getting executives was an issue back in the day. Nowadays we see people with different capital backgrounds, and he refers to these changes in cannabis management as an “inevitable evolution” that allows people to have “real careers”. 

That was the first time he talked about recruiting, one of his “biggest issues at MedMen.” 

The Parent Co. And Jay-Z

- The Parent Company, that's Jay-z. Have you met him?

I’ve met him. That's the deal that I put together at MedMen. Jay-z's title at that company is a title we came up with. We put the deal together, we lubricated the deal, and then we have this, you know, unfortunate James Parker lawsuit which you haven't even asked me about yet. 

James Parker Lawsuit

Former MedMen's CFO, James Parker, was terminated in 2019, and then he sued the firm for approximately $22 million. According to Bierman, he “could not find great talent,” and “went public with a CFO that had never been a CFO before. He was the only CFO that was willing to do it at the time.”  

“I recruited the guy even though he was mediocre because that was the best we could get. (...) As the company grew and as those responsibilities became greater for him as a CFO he couldn't do the job and as opposed to facing the music he walked out in the middle of the day and in California you can walk out and sue people. He tried to extort us,” Bierman said. 

Lobbying Against Home Growing?

- There was a lot of chat about MedMen lobbying against home growing. Was that true? 

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.